
Neromed Pharmaceuticals Private Limited
About Neromed Pharmaceuticals Private Limited
Data last updated:
Neromed Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 14 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2018PTC341774. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neha Srivastava and Rohan Srivastava.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Flat No – 16 S/F Plot No 156 – Kh No 322 Vill Neb Sarai Mehrauli New Delhi 110068, Delhi, India – 110068.
As per the financials filed for FY 2021, the company reported a revenue of ₹33.45 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.05 Lakh (net margin 3.2%) and EBITDA of ₹1.36 Lakh (EBITDA margin 4.1%).
Company details
Contact details
Neromed Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No – 16 S/F Plot No 156 – Kh No 322 Vill Neb Sarai Mehrauli New Delhi 110068, Delhi, India – 110068
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Neromed Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neromed Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Neromed Pharmaceuticals Private Limited, buy the company report.
Financials of Neromed Pharmaceuticals Private Limited
FY 2021 filings availableNeromed Pharmaceuticals Private Limited reported revenue of ₹33.45 Lakh (up 345% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 345% in the latest year. EBITDA rose 356% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.36 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.05 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 4.1% | ||
| Net Profit Margin | 3.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Neromed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neromed Pharmaceuticals Private Limited
Neromed Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neha Srivastava | Director | 14 Nov 2018 | 7 Years 11 Months | Current |
| Rohan Srivastava | Director | 14 Nov 2018 | 7 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Neromed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neromed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neromed Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Neromed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neromed Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Neha Srivastava was appointed as Director on 14 Nov 2018.
Frequently asked questions
Neromed Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 14 November 2018 (8+ years old) and is registered under CIN U51909DL2018PTC341774.
Neromed Pharmaceuticals has 2 current directors:
- Neha Srivastava - Director
- Rohan Srivastava - Director
The latest financial statements of Neromed Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2019 are in the company report.
No. Neromed Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Neromed Pharmaceuticals is U51909DL2018PTC341774. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neromed Pharmaceuticals was incorporated on 14 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Neha Srivastava was appointed as Director on 14 Nov 2018. Rohan Srivastava was appointed as Director on 14 Nov 2018.
The registered office of Neromed Pharmaceuticals is at Flat No – 16 SF Plot No 156 – Kh No 322 Vill Neb Sarai Mehrauli New Delhi 110068, Delhi, India – 110068.
Neromed Pharmaceuticals operates in the trading industry, in the specialty segment.
Neromed Pharmaceuticals can be reached at its registered office: Flat No – 16 SF Plot No 156 – Kh No 322 Vill Neb Sarai Mehrauli New Delhi 110068, Delhi, India – 110068.

